TNF (Tumor Necrosis Factor) recombinant proteins refer to proteins produced by recombinant DNA technology that mimic the biological activity of the naturally occurring TNF, a cytokine involved in inflammation, immune regulation, and apoptosis. These recombinant proteins are typically derived from the TNF-alpha variant, which plays a crucial role in the immune response.

Technical Content

  • Structure and Function:

    • TNF is a trimeric protein, with each subunit consisting of about 157 amino acids. It primarily exists as TNF-alpha, which is produced by various immune cells, including macrophages, T cells, and natural killer (NK) cells.
    • TNF-alpha binds to TNF receptors (TNFR1 and TNFR2) on the cell surface, triggering downstream signaling pathways that lead to inflammation, cell survival, apoptosis, or necrosis, depending on the context and cellular environment.
  • Production:

    • TNF recombinant proteins are typically expressed in bacterial, yeast, or mammalian expression systems. Escherichia coli (E. coli) is commonly used due to its high yield and cost-effectiveness.
    • The gene encoding TNF-alpha is inserted into an expression vector, which is then introduced into the host cells. The expressed protein is subsequently purified using affinity chromatography or other purification techniques to ensure high purity and activity.
  • Applications:

    • Research: TNF recombinant proteins are widely used in research to study the mechanisms of inflammation, immune response, and cell death.
    • Drug Development: TNF is a target in developing therapeutics for inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Recombinant TNF proteins are used in assays to screen potential drug candidates.
    • Diagnostics: TNF levels can be indicative of various disease states, and recombinant TNF proteins are used as standards or controls in immunoassays such as ELISA (Enzyme-Linked Immunosorbent Assay).
  • Advantages:

    • Consistency: Recombinant production ensures a consistent and reproducible source of TNF protein, with well-defined properties.
    • Scalability: Large-scale production is feasible, making recombinant TNF proteins available for extensive research and commercial use.
    • Modifications: Recombinant technology allows for the creation of TNF variants or mutants with altered biological activity, which can be used to dissect specific signaling pathways or develop therapeutics.
  • Limitations:

    • Activity Variability: The biological activity of recombinant TNF proteins may vary depending on the expression system and purification method used.
    • Immunogenicity: In therapeutic applications, recombinant TNF proteins or their fragments can be immunogenic, potentially leading to adverse immune reactions.

In conclusion, TNF recombinant proteins are essential tools in immunology and cell biology research, as well as in the development of anti-inflammatory therapies. Their production and application are central to understanding and manipulating the TNF signaling pathways involved in various diseases.

704.50 704.5 USD
631.00 631.0 USD
631.00 631.0 USD
1,076.50 1076.5 USD
398.50 398.5 USD
523.00 523.0 USD
398.50 398.5 USD
398.50 398.5 USD
643.00 643.0 USD
518.50 518.5 USD
631.00 631.0 USD
631.00 631.0 USD
631.00 631.0 USD